Marcel Bonn-Miller

Dr Marcel Bonn-Miller is a world renowned researcher and pharmaceutical executive with over 18 years of extensive clinical research and development expertise in cannabinoid products for medical use. He has received funding for 27 research grants, published 140 peer-reviewed academic papers, and led or contributed to 19 clinical trials.

Dr Bonn-Miller is the global clinical scientific director of Spectrum Therapeutics, the medical division of Canopy Growth which specialises in the development and commercialisation of validated cannabis medicines. Prior to joining Canopy Growth in January 2019, he was the director of Cannabinoid Research for Zynerba Pharmaceuticals, a leading transdermal cannabinoid pharmaceutical company.